Target intelligence / Profile preview

Polistes exclamans venom components (Pol e venom)

Target
Pol e venom
Molecular classification
Enzyme, Allergen, Peptide, Phospholipase A1, Hyaluronidase, Antigen 5
01

Overview

Polistes exclamans venom components comprise a complex mixture of bioactive proteins and peptides derived from the common paper wasp, also known as the Guinea wasp. The most significant proteinaceous components include Phospholipase A1 (Pol e 1), Hyaluronidase (Pol e 2), and Antigen 5 (Pol e 5), which are the primary allergens responsible for inducing IgE-mediated hypersensitivity in humans [1][5]. Biologically, these components function as a defensive mechanism, utilizing enzymatic activity to degrade tissue and peptides like mastoparan to disrupt cell membranes and trigger inflammatory cascades [6]. In a clinical context, these venom components are the primary targets for Venom Immunotherapy (VIT), where controlled exposure to venom extracts aims to induce immunological tolerance in allergic individuals [2]. Accurate identification of these specific components is essential for component-resolved diagnostics, which helps clinicians distinguish between true Polistes sensitivity and cross-reactivity with other Hymenoptera venoms [3][4].

Other names
Common paper wasp venomGuinea wasp venomPol e allergensPolistes exclamans venom extract
02

Mechanism of action

Venom Immunotherapy (VIT) works by shifting the immune response from a Th2-biased profile to a Th1/Treg-biased profile, increasing the production of IL-10 and venom-specific IgG4 antibodies that block IgE binding to allergens [1][2].

03

Biological functions

DefenseProteolysisHemolysisInduction of IgE-mediated hypersensitivityMembrane disruption
04

Disease associations

AnaphylaxisHymenoptera venom allergyUrticariaAngioedema
05

Safety considerations

Systemic allergic reactions during immunotherapyRisk of life-threatening anaphylaxisCross-reactivity with other Vespidae venoms
06

Interacting drugs

Polistes exclamans venom extract

4 more in the full profile.

07

Biomarkers

Specific IgE (sIgE) to Pol e 1Specific IgE (sIgE) to Pol e 5Skin prick test (SPT) positivityBasophil activation test (BAT)

Beyond the preview

Go deeper on Polistes exclamans venom components (Pol e venom).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polistes exclamans venom components (Pol e venom).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call